Safety and Efficacy of OBX-115 in Advanced/Metastatic Melanoma Resistant to Immune Checkpoint Inhibitors

Conditions: Tumor Skin; Metastatic Melanoma; Melanoma Interventions: Biological: OBX-115 Sponsors: Obsidian Therapeutics, Inc. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials